For: | Sandhir R, Gupta S. Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal. World J Diabetes 2015; 6(12): 1223-1242 [PMID: 26464760 DOI: 10.4239/wjd.v6.i12.1223] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v6/i12/1223.htm |
Number | Citing Articles |
1 |
Lütfiye Özpak, Ayfer Pazarbasi, Işıl Öcal, M. Bertan Yılmaz, Hülya Binokay. Investigation of extracellular matrix genes associated with Alzheimer’s disease in the hippocampus of experimental diabetic model rats. International Journal of Diabetes in Developing Countries 2022; 42(1): 82 doi: 10.1007/s13410-021-00951-7
|
2 |
Iwona Piątkowska-Chmiel, Mariola Herbet, Monika Gawrońska-Grzywacz, Kamil Pawłowski, Marta Ostrowska-Leśko, Jarosław Dudka. Molecular and neural roles of sodium-glucose cotransporter 2 inhibitors in alleviating neurocognitive impairment in diabetic mice. Psychopharmacology 2023; 240(4): 983 doi: 10.1007/s00213-023-06341-7
|
3 |
Joanna Wojsiat, Katarzyna Marta Zoltowska, Katarzyna Laskowska-Kaszub, Urszula Wojda, Christopher Horst Lillig. Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/6435861
|
4 |
Jorge Berlanga-Acosta, Gerardo Guillén-Nieto, Nadia Rodríguez-Rodríguez, Maria Luisa Bringas-Vega, Diana García-del-Barco-Herrera, Jorge O. Berlanga-Saez, Ariana García-Ojalvo, Mitchell Joseph Valdés-Sosa, Pedro A. Valdés-Sosa. Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.560375
|
5 |
Lütfiye Ozpak, Bakiye Göker Bağca. Neuroprotective effects of resveratrol through modulation of PI3K/Akt/GSK‐3β pathway and metalloproteases. IUBMB Life 2024; 76(12): 1199 doi: 10.1002/iub.2902
|
6 |
Maria Rosaria Rizzo, Irene Di Meo, Rita Polito, Maria Chiara Auriemma, Antonio Gambardella, Gabriella di Mauro, Annalisa Capuano, Giuseppe Paolisso. Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment. Pharmacological Research 2022; 176: 106062 doi: 10.1016/j.phrs.2022.106062
|
7 |
Lin Li. The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer’s Disease, Based on a Mechanistic Target of Rapamycin Pathway. CNS Drugs 2017; 31(7): 535 doi: 10.1007/s40263-017-0431-2
|
8 |
Juvenal A. Ríos, Juan Carlos Bórquez, Juan A. Godoy, Juan M. Zolezzi, María Cristina Furrianca, Nibaldo C. Inestrosa. Emerging role of Metformin in Alzheimer’s disease: A translational view. Ageing Research Reviews 2024; 100: 102439 doi: 10.1016/j.arr.2024.102439
|
9 |
Umit Cintosun, Mehmet I. Naharci, Huseyin Doruk. Defining Randomly Measured Glycemic Values As a Risk Factor for Dementia: Accurate and Adequate?. Journal of the American Geriatrics Society 2016; 64(9): 1925 doi: 10.1111/jgs.14192
|
10 |
Rohit Pardeshi, Nityanand Bolshette, Kundlik Gadhave, Ashutosh Ahire, Sahabuddin Ahmed, Tommaso Cassano, Veer Bala Gupta, Mangala Lahkar. Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease. Psychoneuroendocrinology 2017; 83: 159 doi: 10.1016/j.psyneuen.2017.05.004
|
11 |
Smriti Gupta, Vishal Singh, Subramaniam Ganesh, Nitin K. Singhal, Rajat Sandhir. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer’s Disease Pathology: Evidence from In Vitro and In Vivo Studies. ACS Applied Materials & Interfaces 2022; 14(1): 69 doi: 10.1021/acsami.1c15305
|
12 |
Smriti Gupta, Nitin Kumar Singhal, Subramaniam Ganesh, Rajat Sandhir. Extending Arms of Insulin Resistance from Diabetes to Alzheimer’s Disease: Identification of Potential Therapeutic Targets. CNS & Neurological Disorders - Drug Targets 2019; 18(3): 172 doi: 10.2174/1871527317666181114163515
|
13 |
Nimona Ashebir, Hailemariam Hailesilassie, Shimelis Girma, Elias Nigusu, Elias Ezo. Prevalence of Cognitive Impairment and Associated Factors Among Diabetes Mellitus Patients Attending Follow-up Treatment at Fiche General Hospital, North Ethiopia. SAGE Open Nursing 2024; 10 doi: 10.1177/23779608241227752
|
14 |
Milagros Rojas, Mervin Chávez-Castillo, Jordan Bautista, Ángel Ortega, Manuel Nava, Juan Salazar, Edgar Díaz-Camargo, Oscar Medina, Joselyn Rojas-Quintero, Valmore Bermúdez. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World Journal of Diabetes 2021; 12(6): 745-766 doi: 10.4239/wjd.v12.i6.745
|
15 |
Jianhui Wang, Ning Jiang, Feng Liu, Chenran Wang, Wenxia Zhou. Uncovering the intricacies of O-GlcNAc modification in cognitive impairment: New insights from regulation to therapeutic targeting. Pharmacology & Therapeutics 2025; 266: 108761 doi: 10.1016/j.pharmthera.2024.108761
|
16 |
Yu Song, Shanshan Chen, Ju Gao, Jie Lu, Wenwen Xu, Xingjian Lin, Jiu Chen. Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease. Frontiers in Neurology 2021; 12 doi: 10.3389/fneur.2021.673347
|
17 |
Y. Shi, X. Sun, Y. Sun, L. Hou, M. Yao, K. Lian, J. Li, X. Lu, L. Jiang. Elevation of cortical C26:0 due to the decline of peroxisomal β-oxidation potentiates amyloid β generation and spatial memory deficits via oxidative stress in diabetic rats. Neuroscience 2016; 315: 125 doi: 10.1016/j.neuroscience.2015.11.067
|
18 |
Aikaterini Trikkalinou, Athanasia K Papazafiropoulou, Andreas Melidonis. Type 2 diabetes and quality of life. World Journal of Diabetes 2017; 8(4): 120-129 doi: 10.4239/wjd.v8.i4.120
|
19 |
Varda Shoshan-Barmatz, Edna Nahon-Crystal, Anna Shteinfer-Kuzmine, Rajeev Gupta. VDAC1, mitochondrial dysfunction, and Alzheimer's disease. Pharmacological Research 2018; 131: 87 doi: 10.1016/j.phrs.2018.03.010
|
20 |
Mahdieh Anoush, Neda Taghaddosi, Zahra Bokaei Hosseini, Fatemeh Rahmati, Soroush Bijani, Ali Kalantari-Hesari, Mir-Jamal Hosseini. Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats. IBRO Neuroscience Reports 2025; 18: 163 doi: 10.1016/j.ibneur.2025.01.008
|
21 |
Rex Liu, Blythe Durbin‐Johnson, Brian Paciotti, Albert T. Liu, Alyssa Weakley, Xin Liu, Yu‐Jui Yvonne Wan. Metabolic dysfunctions predict the development of Alzheimer's disease: Statistical and machine learning analysis of EMR data. Alzheimer's & Dementia 2024; doi: 10.1002/alz.14101
|
22 |
Luis Jesuino de Oliveira Andrade, Luís Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, Letícia Góes de Carvalho Lourenço, Gabriela Correia Matos de Oliveira. Brain insulin resistance and Alzheimer’s disease: a systematic review. Dementia & Neuropsychologia 2024; 18 doi: 10.1590/1980-5764-dn-2023-0032
|
23 |
J. Mendiola-Precoma, L. C. Berumen, K. Padilla, G. Garcia-Alcocer. Therapies for Prevention and Treatment of Alzheimer’s Disease. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/2589276
|
24 |
Ming-Min Chung, Christopher J. Nicol, Yi-Chuan Cheng, Kuan-Hung Lin, Yen-Lin Chen, Dee Pei, Chien-Hung Lin, Yi-Nuo Shih, Chia-Hui Yen, Shiang-Jiuun Chen, Rong-Nan Huang, Ming-Chang Chiang. Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs. Experimental Cell Research 2017; 352(1): 75 doi: 10.1016/j.yexcr.2017.01.017
|
25 |
Smriti Gupta, Kamalendra Yadav, Shrikant S. Mantri, Nitin K. Singhal, Subramaniam Ganesh, Rajat Sandhir. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer’s Disease. Molecular Neurobiology 2018; 55(12): 8916 doi: 10.1007/s12035-018-0985-0
|
26 |
R. Loera‐Valencia, A. Cedazo‐Minguez, P.A. Kenigsberg, G. Page, A.I. Duarte, P. Giusti, M. Zusso, P. Robert, G. B. Frisoni, Annamaria Cattaneo, M. Zille, J. Boltze, N. Cartier, L. Buee, G. Johansson, B. Winblad. Current and emerging avenues for Alzheimer's disease drug targets. Journal of Internal Medicine 2019; 286(4): 398 doi: 10.1111/joim.12959
|
27 |
André Quincozes-Santos, Larissa Daniele Bobermin, Adriano M. de Assis, Carlos-Alberto Gonçalves, Diogo Onofre Souza. Fluctuations in glucose levels induce glial toxicity with glutamatergic, oxidative and inflammatory implications. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(1): 1 doi: 10.1016/j.bbadis.2016.09.013
|
28 |
John M. Hickey, Neha Sahni, Rajoshi Chaudhuri, Ajit D'Souza, Andrew Metters, Sangeeta B. Joshi, C. Russell Middaugh, David B. Volkin. Effect of acrylodan conjugation and forced oxidation on the structural integrity, conformational stability, and binding activity of a glucose binding protein SM4 used in a prototype continuous glucose monitor. Protein Science 2017; 26(3): 527 doi: 10.1002/pro.3102
|
29 |
Mohammad Zubair, Farha Fatima, Fohad Mabood Husain. Current Thoughts on Dementia. 2022; : 273 doi: 10.1007/978-981-16-7606-2_11
|
30 |
Patrizia Mecocci, Virginia Boccardi, Roberta Cecchetti, Patrizia Bastiani, Michela Scamosci, Carmelinda Ruggiero, Marta Baroni, George Perry, Jesus Avila, Massimo Tabaton, Xiongwei Zhu. A Long Journey into Aging, Brain Aging, and Alzheimer’s Disease Following the Oxidative Stress Tracks. Journal of Alzheimer’s Disease 2018; 62(3): 1319 doi: 10.3233/JAD-170732
|
31 |
Ting-I Chiang, Yi-Hsiang Yu, Chieh-Hsin Lin, Hsien-Yuan Lane. Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress. Clinical Psychopharmacology and Neuroscience 2021; 19(3): 423 doi: 10.9758/cpn.2021.19.3.423
|
32 |
Tian Li, Juan‐Juan Jiao, Christian Hölscher, Mei‐Na Wu, Jun Zhang, Jia‐Qing Tong, Xue‐Fan Dong, Xue‐Song Qu, Yue Cao, Hong‐Yan Cai, Qiang Su, Jin‐Shun Qi. A novel GLP‐1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease. Hippocampus 2018; 28(5): 358 doi: 10.1002/hipo.22837
|
33 |
Zhike Zhou, Jun Bai, Shanshan Zhong, Rongwei Zhang, Kexin Kang, Xiaoqian Zhang, Ying Xu, Chuansheng Zhao, Mei Zhao, Fabiana Morroni. Downregulation of PIK3CB Involved in Alzheimer’s Disease via Apoptosis, Axon Guidance, and FoxO Signaling Pathway. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/1260161
|
34 |
Saurabh Kumar Jha, Niraj Kumar Jha, Dhiraj Kumar, Rashmi K. Ambasta, Pravir Kumar. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(5): 1132 doi: 10.1016/j.bbadis.2016.06.015
|
35 |
Sebastian Bertram, Klara Brixius, Christian Brinkmann. Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patients. Endocrine 2016; 53(2): 350 doi: 10.1007/s12020-016-0976-8
|
36 |
Tapan Behl, Arpita Arora, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harrasi, Simona Bungau, Ebrahim Mostafavi. Molecular and Biochemical Pathways Encompassing Diabetes Mellitus
and Dementia. CNS & Neurological Disorders - Drug Targets 2022; 21(7): 542 doi: 10.2174/1871527320666211110115257
|
37 |
Michael R. D’Andrea. Intracellular Consequences of Amyloid in Alzheimer's Disease. 2016; : 155 doi: 10.1016/B978-0-12-804256-4.00008-5
|
38 |
Brett D. Story, Matthew E. Miller, Allison M. Bradbury, Emily D. Million, Dongsheng Duan, Toloo Taghian, Dominik Faissler, Deborah Fernau, Sidney J. Beecy, Heather L. Gray-Edwards. Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases. Frontiers in Veterinary Science 2020; 7 doi: 10.3389/fvets.2020.00080
|